GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹151 Cr | ₹238 Cr | ₹177 Cr | ₹181 Cr | ₹338 Cr |
What is the latest Capital Work in Progress ratio of GLAND PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹238 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹181 Cr |
| Mar2021 | ₹338 Cr |
How is Capital Work in Progress of GLAND PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | -36.71 | |
| Mar2024 | ₹238 Cr | 34.23 | |
| Mar2023 | ₹177 Cr | -1.95 | |
| Mar2022 | ₹181 Cr | -46.49 | |
| Mar2021 | ₹338 Cr | - | |
Compare Capital Work in Progress of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹28,372.8 Cr | 1% | 1.9% | 1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 1% |
1.9% |
1% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses